Background {#Sec1}
==========

Hepatocellular carcinoma (HCC) is a common primary cancer around the word, which ranks the 6^th^ in cancer morbidity and the 3^rd^ in cancer mortality \[[@CR1], [@CR2]\]. In recent years, advanced traditional treatments like transcatheter hepatic arterial chemoembolization (TACE) and the application of chemotherapy drug like paclitaxel \[[@CR3]\] and doxorubicin \[[@CR4]\], have extended HCC patients' lives to a certain degree. However, the prognosis of most HCC cases remains disappointing with the 5-year survival rate of approximately 7% \[[@CR5]\]. With the development of science and technology, targeted therapy has been an option for HCC treatment. Hence, it is urgent to figure out possible targets for HCC.

It is discovered that many factors and mechanisms can affect the development of cancer. As reported, c-Fos promotes cell stemness in head and neck squamous cell carcinoma \[[@CR6]\]. In recent years, circular RNAs (circRNAs), a class of non-coding RNAs, are reported as new regulators that participate in diverse biological functions in eukaryotic organisms \[[@CR7]\]. Recently, increasing studies manifested that circRNAs could regulate cancer development through a competing endogenous RNA (ceRNA) network via sponging certain microRNAs (miRNAs) \[[@CR8], [@CR9]\]. MiRNAs are another type of non-coding RNAs that also play important regulatory roles in cancer \[[@CR10], [@CR11]\]. For example, miR-24-3p restrains cell cycle and invasion in pancreatic ductal adenocarcinoma by targeting LAMB3 \[[@CR12]\]. MiR-203 is upregulated in breast cancer and regulates cell growth and stemness via targeting SOCS3 \[[@CR10]\]. Previously, a circRNA derived from DENN domain containing 4C (circ-DENND4C) has been newly recognized \[[@CR13]\]. As a hypoxia-associated RNA, circ-DENND4C exhibited a high level and promoted cell proliferation in breast cancer \[[@CR14]\]. It was also reported that circ-DENND4C was involved in the regulation of blood-tumor barrier in glioma \[[@CR13]\]. However, the function and mechanism of circ-DENND4C in HCC remain largely unknown.

Our study investigated the role and molecular mechanism of circ-DENND4C in HCC. It was found that circ-DENND4C was up-regulated in HCC cells and activated Wnt pathway to aggravate cell growth, stemness and invasion in HCC by acting as a ceRNA. These findings might be helpful to develop novel therapeutic strategies for HCC patients.

Materials {#Sec2}
=========

Cell culture {#Sec3}
------------

HCCLM3, Huh7, HepG2 and Hep3B were purchased as the human liver cancer cell lines, and THLE-3 served as a normal liver cell line. All cell lines were obtained from Cell Biology of the Chinese Academy of Sciences (Shanghai, China). All above cells were cultured in DMEM medium (Invitrogen, Carlsbad, CA) containing 100 U/ml penicillin, 10% fetal bovine serum (FBS) and 100 mg/ml streptomycin (all, Invitrogen) at 37°C with 5% CO~2~.

Cell transfection {#Sec4}
-----------------

Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was used to transfect cells with indicated plasmids. Cells were put in the six-well plate (2 × 10^5^ cells/well) for 24-hour cultivation. Lipofectamine RNAiMAX reagent (Invitrogen) was utilized for shRNA transfection in line with the protocols of suppliers. HepG2 and Huh7 cells were subjected to transfection with 2 μg of shRNA for two days. qRT-PCR was used to estimate transfection efficiency.

### RNA extraction and quantitative real-time PCR (qRT-PCR) {#Sec5}

Based on protocols of suppliers, TRIzol method (Invitrogen) was utilized to separate the total RNA. Briefly, cells were supplemented with 1 ml of TRIzol for dissolution and cultivation for five minutes. Then, cells were subjected to centrifugation for separating after they were mixed forcefully with chloroform. After that, isopropanol (1:1) was used to precipitate the supernatant and 75% ethanol was used to wash them. In the end, RNase-free H~2~O was applied to dissolve the RNA pellet. The RT-PCR kit (Promega, Madison, WI) was adopted to produce complementary DNA from RNA. In accordance with the standard procedures, real-time PCR reaction was carried out.

### Colony-formation assay {#Sec6}

Six well plates (800 cells/well) were used to cultivate cells in the drippy incubator at 37 °C. The process lasted for 14 days. After fixing cells with 4% formaldehyde, 0.5% Crystal Violet (Sigma-Aldrich, Miamisburg, OH) was adopted to stain the colonies. Finally, colonies with over 50 cells were calculated manually.

### Transwell invasion assay {#Sec7}

For transwell invasion, the top chamber coated with Matrigel (BD Biosciences, Franklin Lakes, NJ) was adopted to cultivate the cells (3 × 10^5^ cells/well) in serum-free medium. The medium which included 10% FBS was put into the lower chamber. After 24 h, a cotton swab was used to eliminate the cells which did not invade into the lower chamber. Thereafter, cells crossed the membrane were fixated by 4% formaldehyde and dyed with crystal violet. Finally, Nikon EclipseTi microscope (Olympus) was applied to obtain the images.

Cell cycle assay {#Sec8}
----------------

After transfection, cells were cultured in 6-well plates (3 × 10^5^ cells/well) and collected after 10 min of centrifugation. Afterwards, cells were rinsed in PBS and then subjected to propidium iodide (PI) dying in the dark. Then, cell proportions in G0/G1, S, and G2/M phases were examined by flow cytometry (BD Biosciences) as guided.

TUNEL assay {#Sec9}
-----------

One Step TUNEL Apoptosis Assay Kit (Beyotime, Jiangsu, China) was used to estimate cell apoptosis. In short, cells in 6-well plates (1 × 10^5^ cells/well) were processed with the TUNEL kit, and then subjected to DAPI (Beyotime) staining. By fluorescent microscope (Olympus), apoptotic cells was imaged.

Fluorescence In Situ Hybridization (FISH) {#Sec10}
-----------------------------------------

In order to test the localization of circ-DENND4C, RNAscope Multiplex Fluorescent Reagent Kit v2 (Advanced Cell Diagnostics, Inc., Newark, NJ, USA) was utilized to conduct FISH assay. Briefly, 4% paraformaldehyde was adopted to fix cells (1 × 10^4^) for half an hour. After digested by protease III prior, cells were subjected to take hybridization by the specific probes of target RNA at 40 °C for two hours. TSA plus Cyanine3, HRP-labeled oligos, amplifier and preamplifier were subjected to the hybridization by turn at 40 °C. Hoechst was adopted to stain the nuclei. Images were obtained by Zeiss LSM 710 confocal microscope (Jena, Germany).

### Immunofluorescence assay {#Sec11}

The pre-cooled PBS was used to rinse the cells in 6-well plates (2 × 10^4^ cells/well) for 3 times and 4% paraformaldehyde was employed to fix the cells deposited in plates of 48-well. After that, cells were subjected to permeabilization by 0.5% Triton X-100 at 37°C for ten minutes. Then, 3% BSA was added for blockading the nonspecific binding. With Cy3-conjugated goat anti-mouse IgG (Millipore) as the control, cells were stained with β-catenin antibody to obtain the location of β-catenin. For observing Ki67 expression, Ki67 cell proliferation Detection Kit (Beyotime) was adopted to culture cells at least one hour. Afterwards, PBS was adopted to rinse the cells for 3 times and DAPI was taken to stain them at 37 °C for 15 min. With the help of a Nikon Eclipse Ti Fluorescence Microscopy (Olympus), the images were obtained.

### Subcellular fractionation assay {#Sec12}

PARIS™ Kit (Ambion, Austin, TX) was used to conduct subcellular fractionation assay in 1 × 10^4^ cells. Firstly, cell fractionation buffer was used to resuspend the collected cells. Then, cells were placed on ice for ten minutes. After centrifugation, the cell disruption buffer was utilized to conserve the nuclear pellet and supernatant for the extraction of RNA.

RNA immunoprecipitation {#Sec13}
-----------------------

Magna RIP™ RNA-Binding Protein Immunoprecipitation Kit (Millipore, Billerica, MA) was adopted for conducting the RIP assays in 1 × 10^7^ cells. Ago2 antibody was utilized to conduct the RIP assay and qRT-PCR was utilized to detect the co-precipitated RNA. IgG was seen as a negative control.

### RNA pull down assay {#Sec14}

For pull down assays, Biotin RNA Labeling Mix (Roche, Basel, Switzerland) and T7 RNA polymerase were utilized to take the in vitro transcription for getting circ-DENND4C sequence to obtain biotin-labelled circ-DENND4C, and sequence without biotin labelling acted as the negative control. Then, cell lysates from 1 × 10^7^ cells were subjected to circ-DENND4C sequences labelled with or without biotin for four hours at room temperature (RT). After that, streptavidin-conjugated agarose beads were added and the mixtures were further incubated for 4 h. Then, the pulled down RNAs were detected by qRT-PCR.

### Western blotting {#Sec15}

Cells were crushed by radioimmune precipitation assay buffer (Beyotime) and then taken to SDS-PAGE. Then, cells were transferred by Nitrocellulose membrane (Beyotime Biotechnology) and cultivated by the primary antibodies against Cyclin D1, CDK4, β-catenin, Bcl-2, Bax and loading control GAPDH. After that, the secondary antibodies conjugated with horseradish peroxidase were adopted for visualizing. All antibodies were procured from Abcam (Cambridge, MA).

### Luciferase reporter assay {#Sec16}

Cells (1.5 × 10^5^) were seeded in 96-well plates and the consistence of each well was 5000 cells. At 24-hour cultivation, the mixture was formed firefly luciferase reporter (Promega, Madison, WI), pRL-CMV Renilla luciferase reporter (Promega) and small RNA was adopted to transfect the cells transiently. 48 h later, dual-luciferase reporter assay system (Promega) was employed to measure the luciferase activity.

### In vivo tumor formation assay {#Sec17}

The male nude mice, aged about 6-week old, were procured from the National Laboratory Animal Center (Beijing, China) and housed under SPF-condition, with the approval from the Animal Research Ethics Committee of the Fifth Affiliated Hospital of Sun Yat-sen University. 5 × 10^6^ transfected cells were subcutaneously injected into mice for 28-day of tumor formation purposes. Tumor volume was monitored every 4 days. The mice were killed prior to excising tumors, and then tumor samples were used for weight assessment and further analysis.

### Immunohistochemistry (IHC) {#Sec18}

The tumor tissue samples acquired from in vivo tumor formation assay were prepared for fixing in 4% paraformaldehyde, and then embedded in paraffin. The consecutive sections of 4 μm thick were used for IHC assay using the specific primary antibodies and secondary antibodies (Abcam).

### Statistical analysis {#Sec19}

Mean ± standard deviation (SD) was used for data presentation. Each experiment was repeated at least three times. The results were estimated by Student's t-test and one-way ANOVA using GraphPad PRISM 6 (GraphPad, San Diego, CA). P \< 0.05 was supposed to be significant.

Results {#Sec20}
=======

Circ-DENND4C regulated HCC cell proliferation, apoptosis, invasion and stemness {#Sec21}
-------------------------------------------------------------------------------

We initially detected circ-DENND4C expression in HCC cell lines (HCCLM3, HepG2, Huh7 and Hep3B) and normal human liver epithelial cell line (THLE-3). As manifested in Fig. [1](#Fig1){ref-type="fig"}a, the expression of circ-DENND4C was notably higher in HCC cells than that in THLE-3 cells. HepG2 and Huh7 cells were used to conduct following assays for that they exhibited highest expression of circ-DENND4C. Then, we started to verify the circular characteristic of circ-DENND4C. Convergent primers were designed to amplify DENND4C while divergent primers were designed to amplify circ-DENND4C. cDNA and gDNA were applied as the templates. Gel electrophoresis revealed that circ-DENND4C was amplified by divergent primers in only cDNA while DENND4C was amplified by convergent primers in both cDNA and gDNA (Fig. [1](#Fig1){ref-type="fig"}b). Next, we treated HepG2 and Huh7 cells with actinomycin D (ActD). The results disclosed that circ-DENND4C was not impacted while the level of linear DENND4C was obviously decreased under ActD treatment (Fig. [1](#Fig1){ref-type="fig"}c). Above results verified the abnormal expression and circular characteristic of circ-DENND4C in HCC. Thus, we continued to explore the function of circ-DENND4C in HCC. Before functional assays, knockdown efficiency of circ-DENND4C was verified (Fig. [1](#Fig1){ref-type="fig"}d). Then, we disclosed that circ-DENND4C knockdown decreased the proliferation of HCC cells (Fig. [1](#Fig1){ref-type="fig"}e, f, Additional file [1](#MOESM1){ref-type="media"}: Figure S1A). Further, flow cytometry analysis showed that silenced circ-DENND4C induced cell cycle arrest (Fig. [1](#Fig1){ref-type="fig"}g). In TUNEL assay, circ-DENND4C depletion elevated the apoptosis rates of HCC cells (Fig. [1](#Fig1){ref-type="fig"}h, Additional file [1](#MOESM1){ref-type="media"}: Figure S1B). Later, the levels of cell cycle-related proteins (Cyclin D1, CDK4) and apoptosis-associated proteins (Bcl-2, Bax) were tested in sh-circ-DENND4C\#1/2 transfected cells. The results demonstrated that circ-DENND4C deficiency decreased the levels of Cyclin D1, CDK4 and Bcl-2 while increased that of Bax (Fig. [1](#Fig1){ref-type="fig"}i). Besides, transwell assay indicated the weakened HCC cell invasive ability in response to circ-DENND4C depletion (Fig. [1](#Fig1){ref-type="fig"}j). It was well known that tumor formation was associated with high differentiation of stem cells. Thus, the mRNA and protein levels of OCT4, SOX2 and NANOG (biomarkers of stemness) were examined by qRT-PCR and western blot. Results implied that OCT4, SOX2 and NANOG levels were all decreased in HCC cells transfected with sh-circ-DENND4C\#1/2 (Fig. [1](#Fig1){ref-type="fig"}k, l). All data suggested that circ-DENND4C facilitated HCC cell proliferation, cell cycle, stemness, invasion and repressed HCC cell apoptosis.Fig. 1Circ-DENND4C regulated HCC cell growth, invasion and stemness. **a** qRT-PCR examined circ-DENND4C expression in HCC cells and normal liver epithelial cells. **b**, **c** Gel electrophoresis and ActD treatment verified circular characteristic of circ-DENND4C. **d** qRT-PCR verified knockdown efficiency of sh-circ-DENND4C in HCC cells. **e**, **f**. Immunofluorescence staining assay (scale bar = 30 μm) and colony formation assay detected the proliferation of HCC cells transfected with sh-circ-DENND4C\#1/2. **g** Cell cycle was analyzed by flow cytometry upon circ-DENND4C knockdown. **h** TUNEL assay (scale bar = 100 μm) revealed HCC cell apoptosis with transfection of sh-circ-DENND4C\#1/2. **i** The protein levels of Cyclin D1, CDK4, Bcl-2 and Bax were determined through western blot analysis. **j** Transwell assay (scale bar = 100 μm) detected cell invasion in HCC cells transfected with sh-circ-DENND4C\#1/2. **k**, **l** qRT-PCR and western blot detected mRNA and protein levels of stemness biomarkers in HCC cells upon circ-DENND4C depletion. \*P \< 0.05, \*\*P \< 0.01

Activation of Wnt/β-catenin signaling pathway rescued circ-DENND4C depletion-mediated effects on HCC cells {#Sec22}
----------------------------------------------------------------------------------------------------------

Then, we sought the potential downstream pathways of circ-DENND4C in HCC. Activators of Hedgehog pathway, NOTCH pathway, Wnt/β-catenin pathway and PI3K/AKT pathway were used. The result revealed that only LiCl (activator of Wnt/β-catenin pathway) could rescue the suppressive effect of circ-DENND4C knockdown on HCC cell proliferation (Fig. [2](#Fig2){ref-type="fig"}a). Then, we detected levels of Wnt/β-catenin pathway associated proteins upon circ-DENND4C knockdown. It was disclosed in western blot analysis that protein levels of p-GSK3β, c-Myc, β-catenin and MMP7 were all reduced in cells transfected with sh-circ-DENND4C\#1/2 (Fig. [2](#Fig2){ref-type="fig"}b). Later, western blot analysis and Immunofluorescence assay confirmed that circ-DENND4C knockdown could hinder the translocation of β-catenin into nucleus (Fig. [2](#Fig2){ref-type="fig"}c, d). Next, rescue assays were conducted to explore the influence of Wnt/β-catenin pathway on HCC cells with circ-DENND4C depletion. Colony formation assay disclosed that the treatment of LiCl could counteract the suppressive effect of silenced circ-DENND4C on HCC cell proliferation (Fig. [2](#Fig2){ref-type="fig"}e). Further, the inhibitory role of circ-DENND4C knockdown in cell cycle was also neutralized by treating LiCl (Fig. [2](#Fig2){ref-type="fig"}f). TUNEL assay displayed that LiCl abolished the facilitative effect on HCC cell apoptosis caused by circ-DENND4C depletion (Fig. [2](#Fig2){ref-type="fig"}g, Additional file [1](#MOESM1){ref-type="media"}: Figure S1C). It was also observed that the effect of circ-DENND4C deficiency on proteins related to cell cycle and apoptosis was abrogated after the treatment of LiCl (Fig. [2](#Fig2){ref-type="fig"}h). Besides, LiCl treatment recovered the weakened HCC cell invasion caused by circ-DENND4C knockdown (Fig. [2](#Fig2){ref-type="fig"}i). Further, treatment of LiCl countervailed the expression changes of OCT4, SOX2, NANOG at both mRNA and protein levels in circ-DENND4C-inhibited cells (Fig. [2](#Fig2){ref-type="fig"}j, k). Thus, we summarized that circ-DENND4C regulated HCC cell growth, invasion and stemness via activating Wnt/β-catenin signaling.Fig. 2Activated Wnt/β-catenin pathway rescued the effects of circ-DENND4C suppression on HCC cells. **a** Activators of different signaling pathways were used in immunofluorescence staining assay. **b** Western blot detected Wnt pathway-associated proteins upon circ-DENND4C depletion. **c**, **d** The distribution of β-catenin in cells transfected with sh-NC or sh-circ-DENND4C\#1 was determined by western blot analysis and immunofluorescence assay (scale bar = 30 μm). **e** Colony formation assay detected proliferation of HCC cells transfected with sh-NC, sh-circ-DENND4C\#1 or sh-circ-DENND4C\#1+LiCl. **f** Flow cytometry assessed cell cycle in sh-NC, sh-circ-DENND4C\#1 or sh-circ-DENND4C\#1+LiCl group. **g** TUNEL assay (scale bar = 100 μm) revealed HCC cell apoptosis with transfection of sh-NC, sh-circ-DENND4C\#1 or sh-circ-DENND4C\#1+LiCl. **h** Cyclin D1, CDK4, Bcl-2 and Bax protein levels in each group were confirmed by western blot assay. I. Transwell assay (scale bar = 100 μm) detected cell invasion in HCC cells transfected with sh-NC, sh-circ-DENND4C\#1 and sh-circ-DENND4C\#1+LiCl. J-K. qRT-PCR and western blot detected protein levels of stemness biomarkers in HCC cells transfected with sh-NC, sh-circ-DENND4C\#1 and sh-circ-DENND4C\#1+LiCl. \*P \< 0.05, \*\*P \< 0.01

Circ-DENND4C sponged miR-195-5p {#Sec23}
-------------------------------

To further explore the molecular mechanism of circ-DENND4C in HCC, we first detected the subcellular localization of circ-DENND4C. It was disclosed that circ-DENND4C was mainly located in cytoplasm of HCC cells (Fig. [3](#Fig3){ref-type="fig"}a, b). Cytoplasmic distribution of circ-DENND4C indicated the post-transcriptional regulation of circ-DENND4C in HCC cells. Since ceRNA mechanism is a typical post-transcriptional network, we supposed that circ-DENND4C might serve as a ceRNA in HCC. By using "starBase" \[[@CR15]\], 9 miRNAs were identified under the screening condition that strict stringency of CLIP data and at least 5 supported AGO CLIP-seq experiments. Next, it was displayed that only miR-195-5p and miR-6838-5p were significantly pulled down by circ-DENND4C biotin probe, while other not (Fig. [3](#Fig3){ref-type="fig"}c). The following RIP assay indicated that circ-DENND4C co-existed with miR-195-5p rather than miR-6838-5p in anti-Ago2 group (Fig. [3](#Fig3){ref-type="fig"}d). Meanwhile, we discovered that the expression of miR-195-5p was down-regulated in HCC cells while that of miR-6838-5p didn't exhibit difference (Fig. [3](#Fig3){ref-type="fig"}e). In this regard, miR-195-5p was then proposed as the downstream of circ-DENND4C in HCC. Further, we found the binding sequences of miR-195-5p to circ-DENND4C and mutated these sequences as well (Fig. [3](#Fig3){ref-type="fig"}f). Besides, the overexpression efficiency of miR-195-5p was verified in qRT-PCR analysis (Fig. [3](#Fig3){ref-type="fig"}g). As revealed in luciferase reporter assay, miR-195-5p overexpression notably decreased the luciferase activity of circ-DENND4C-wt vectors while that of circ-DENND4C-mut vectors was not affected (Fig. [3](#Fig3){ref-type="fig"}h). Similarly, RNA pull down assay further verified the interaction of circ-DENND4C with miR-195-5p at predicted binding sequences (Fig. [3](#Fig3){ref-type="fig"}i). In conclusion, circ-DENND4C functioned as a sponge of miR-195-5p in HCC.Fig. 3Circ-DENND4C sponged miR-195-5p. **a**, **b** Subcellular fractionation assay and FISH assay (scale bar = 10 μm) were carried out to detect the subcellular location of circ-DENND4C in HCC cells. **c** RNA pull down assay detected enrichments of 9 candidate miRNAs in no-biotin/biotin-labeled circ-DENND4C probe. **d** RIP assay detected miR-195-5p, circ-DENND4C and miR-6838-5p enrichments in Ago2 and IgG group. **e** qRT-PCR examined miR-195-5p and miR-6838-5p expressions in HCC cells and normal THLE-3 cells. **f** Binding sequences between circ-DENND4C and miR-195-5p was predicted from starBase. **g** qRT-PCR verified the overexpression efficiency of miR-195-5p. **h** Luciferase activity of circ-DENND4C-wt/mut reporters was examined after miR-195-5p overexpression. **i** RNA pull down assay examined enrichment of circ-DENND4C pulled down by biotinylated miR-195-5p-wt/mut. \*\*P \< 0.01, n.s. meat no significance

MiR-195-5p targeted TCF4 and negatively modulated TCF4 {#Sec24}
------------------------------------------------------

To support ceRNA hypothesis, we explored the target genes of miR-195-5p. According to the result of "starBase", TCF4 was predicted as target gene of miR-195-5p. More importantly, TCF4 has been widely reported to activate Wnt/β-catenin pathway in many cancers, including HCC \[[@CR16]--[@CR18]\]. We first observed that TCF4 was notably overexpressed in HCC cells compared with normal THLE-3 cells (Fig. [4](#Fig4){ref-type="fig"}a). Then, RIP assay was conducted to verify the interaction between miR-195-5p and TCF4 mRNA. The result disclosed that both miR-195-5p and TCF4 were significantly enriched in RNA-induced silenced complexes (RISCs) (Fig. [4](#Fig4){ref-type="fig"}b). Next, the binding sites between TCF4 3′UTR and miR-195-5p were disclosed and we mutated the binding sequences in TCF4 (Fig. [4](#Fig4){ref-type="fig"}c). RNA pull down assay revealed that TCF4 was notably pulled down by biotinylated miR-195-5p-wt while had no response to biotinylated miR-195-5p-mut (Fig. [4](#Fig4){ref-type="fig"}d). Further, we down-regulated the expression of miR-195-5p in HCC cells as verified by qRT-PCR analysis (Fig. [4](#Fig4){ref-type="fig"}e). Subsequently, luciferase reporter assay was carried out and results revealed that luciferase activity of wild type TCF4 reporter was significantly decreased by miR-195-5p overexpression and enhanced by miR-195-5p knockdown. However, the luciferase activity of mutant type TCF4 showed no change in cells transfected with miR-195-5p-mimics/inhibitor (Fig. [4](#Fig4){ref-type="fig"}f). Further, we examined the effect of miR-195-5p overexpression or circ-DENND4C knockdown on TCF4 expression in HCC. As expected, TCF4 mRNA and protein expressions were both down-regulated by miR-195-5p overexpression or by circ-DENND4C knockdown in HCC cells (Fig. [4](#Fig4){ref-type="fig"}g, h). Thus, we concluded that TCF4 was downstream of circ-DENND4C/miR-195-5p axis in HCC.Fig. 4MiR-195-5p targeted TCF4 and negatively modulated TCF4. **a** qRT-PCR was conducted to examine TCF4 expression in HCC cells and normal THLE-3 cells. **b** RIP assay verified the interaction between TCF4 and miR-195-5p in HepG2 and Huh7 cells. **c** Binding sites between TCF4 and miR-195-5p was predicted and the mutant sequences were constructed. **d** RNA pull down assay detected the interaction between TCF4 and miR-195-5p. **e** Knockdown efficiency of miR-195-5p was verified by qRT-PCR analysis. **f** Luciferase reporter assay detected luciferase activity of TCF4-wt/mut reporters under miR-195-5p overexpression or depletion. G-H. Effect of miR-195-5p overexpression or circ-DENND4C depletion on TCF4 mRNA and protein expressions was examined through qRT-PCR and western blot. \*\*P \< 0.01

Circ-DENND4C mediated HCC cell growth, invasion and stemness via up-regulating TCF4 {#Sec25}
-----------------------------------------------------------------------------------

Finally, rescue assays were conducted to examine the effects of TCF4 on circ-DENND4C knockdown-mediated HCC cell development. Immunofluorescence staining and colony formation assay disclosed that TCF4 overexpression restored the suppressive effect of circ-DENND4C depletion on HCC cell proliferation (Fig. [5](#Fig5){ref-type="fig"}a, b). Furthermore, circ-DENND4C silencing-mediated inhibition on cell cycle was also recovered by TCF4 overexpression (Fig. [5](#Fig5){ref-type="fig"}c). TUNEL assay disclosed that TCF4 up-regulation restored the facilitating effect of circ-DENND4C depletion on HCC cell apoptosis (Fig. [5](#Fig5){ref-type="fig"}d). Through western blot analysis, overexpressed TCF4 rescued the effect of silenced circ-DENND4C on the levels of proteins involved in cell cycle and apoptosis (Fig. [5](#Fig5){ref-type="fig"}e). Moreover, TCF4 overexpression reversed the weakened HCC cell invasion caused by circ-DENND4C depletion (Fig. [5](#Fig5){ref-type="fig"}f). Additionally, the expression levels of OCT4, SOX2 and NANOG decreased by knockdown of circ-DENND4C were further normalized by TCF4 up-regulation at both mRNA and protein levels (Fig. [5](#Fig5){ref-type="fig"}g, h). In sum, circ-DENND4C mediated HCC cell growth, invasion and stemness via up-regulating TCF4.Fig. 5Circ-DENND4C mediated HCC cells proliferation, apoptosis and invasion via up-regulating TCF4. **a**, **b** Immunofluorescence staining assay (scale bar = 30 μm) and colony formation assay detected the proliferation of HCC cells transfected with sh-NC, sh-circ-DENND4C\#1 and sh-circ-DENND4C\#1+pcDNA3.1-TCF4. **c** Flow cytometry was used to analyze cell cycle in the groups of sh-NC, sh-circ-DENND4C\#1 and sh-circ-DENND4C\#1+pcDNA3.1-TCF4. **d** TUNEL assay (scale bar = 100 μm) revealed HCC cell apoptosis by transfecting sh-NC, sh-circ-DENND4C\#1 and sh-circ-DENND4C\#1+pcDNA3.1-TCF4. **e** Cyclin D1, CDK4, Bcl-2 and Bax protein levels were tested in each group. **f** Transwell assay (scale bar = 100 μm) detected cell invasion in HCC cells transfected with sh-NC, sh-circ-DENND4C\#1 and sh-circ-DENND4C\#1+pcDNA3.1-TCF4. **g**, **h** qRT-PCR and western blot detected the protein levels of stemness biomarkers in HCC cells transfected with sh-NC, sh-circ-DENND4C\#1 and sh-circ-DENND4C\#1+pcDNA3.1-TCF4. \*P \< 0.05, \*\*P \< 0.01

Circ-DENND4C up-regulates TCF4 to facilitate HCC tumor growth in vivo {#Sec26}
---------------------------------------------------------------------

Subsequently, we investigated whether circ-DENND4C regulate tumor growth by increasing TCF4 expression. At first, we subcutaneously injected HepG2 cells transfected with sh-NC, sh-circ-DENND4C\#1 or sh-circ-DENND4C\#1+pcDNA3.1-TCF4 into nude mice. As a result, we observed that the size of subcutaneous tumors was remarkably decreased by circ-DENND4C knockdown but was further normalized in sh-circ-DENND4C\#1+pcDNA3.1-TCF4 group (Fig. [6](#Fig6){ref-type="fig"}a). Accordingly, we recorded that the tumor growth was obstructed in circ-DENND4C-depleted group but recovered after TCF4 upregulation (Fig. [6](#Fig6){ref-type="fig"}b). Also, the weight of tumors was evidently reduced in sh-circ-DENND4C\#1 group but was further restored in the group of sh-circ-DENND4C\#1+pcDNA3.1-TCF4 (Fig. [6](#Fig6){ref-type="fig"}c). IHC assay unveiled that TCF4 overexpression could offset the inhibitory effect of circ-DENND4C depletion on the positivity of Ki67 and PCNA (two well-known proliferation markers) in above tumors (Fig. [6](#Fig6){ref-type="fig"}d). All experimental data suggested that circ-DENND4C accelerated HCC progression by targeting miR-195-5p/TCF4 axis and activating Wnt/β-catenin pathway (Fig. [6](#Fig6){ref-type="fig"}e).Fig. 6Circ-DENND4C increased TCF4 expression to hasten tumor growth in HCC. **a**--**c** The representative images, growth curve and weight of excised tumors were displayed in sh-NC, sh-circ-DENND4C\#1 and sh-circ-DENND4C\#1+pcDNA3.1-TCF4 groups. **d** Ki67 and PCNA expression in tumors from indicated groups was confirmed by IHC assay (scale bar = 50 μm) in each group. **e** Schematic diagram was generated to demonstrate the effect of circ-DENND4C/miR-195-5p/TCF4/Wnt/β-catenin pathway on HCC progression. \*\*P \< 0.01

Discussion {#Sec27}
==========

The present study first found the high expression of circ-DENND4C in HCC cells, which established the research value of circ-DENND4C in HCC. Then, cell proliferation, apoptosis and invasion assays were conducted to examine the function of circ-DENND4C in HCC cells. All the results disclosed that circ-DENND4C facilitated HCC cell proliferation, invasion and repressed HCC cell apoptosis. Also, expression levels of stemness biomarkers were examined, and it was disclosed that silencing circ-DENND4C notably down-regulated the expression of stemness biomarkers at both mRNA and protein levels. Next, we sought for the downstream pathway of circ-DENND4C in HCC. Interestingly, LiCl, the activator of Wnt/β-catenin pathway, was found to rescue circ-DENND4C knockdown-mediated effects on HCC cells. The oncogenic role of Wnt pathway was initially recognized by that ectopic expression of Wnt-1 could facilitate tumor formation in mammary tissues of mouse \[[@CR19]\]. Our study found that circ-DENND4C could activate Wnt/β-catenin pathway to exacerbate cell growth, invasion and stemness in HCC.

After that, we examined the subcellular location of circ-DENND4C, and data revealed that circ-DENND4C was principally distributed in the cytoplasm of HCC cells. Thus, we wondered if circ-DENND4C functioned as a ceRNA to up-regulate certain mRNA so as to activate Wnt/β-catenin pathway. CeRNA network is a typical post-transcriptional regulatory mechanism which has been reported in various cancers, including HCC. For example, lncRNA MEG3 represses HCC cell growth via up-regulating SOX11 through sponging miR-9-5p \[[@CR20]\]. LncRNA miat serves as a ceRNA to modulate sirt1 by acting as a miR-22-3p sponge in HCC cellular senescence \[[@CR21]\]. LncRNA MALAT1 inhibits miR-124-3p expression and promotes slug expression to induce tumor metastasis in HCC \[[@CR22]\]. In our study, we identified that circ-DENND4C acted as a sponge of miR-195-5p to up-regulate TCF4 expression in HCC cells. TCF4 is a famous transcription factor which has been widely reported to activate Wnt/β-catenin pathway. Previous study indicated that miR-155 targets TCF4 to exacerbate acute kidney injury via regulating Wnt/β-catenin signaling pathway \[[@CR23]\]. LINC01197 inhibits the activity of Wnt/β-catenin pathway via disturbing the binding of TCF4 to β-catenin in pancreatic adenocarcinoma \[[@CR24]\]. The final rescue assays indicated that circ-DENND4C mediated HCC cellular progression in vitro and in vivo via up-regulating TCF4.

Conclusion {#Sec28}
==========

In conclusion, our research unveiled that circ-DENND4C functioned as a ceRNA to facilitate HCC cell proliferation, cell cycle, invasion, stemness via up-regulation of TCF4 and activation of Wnt/β-catenin pathway. This research might give innovative directions to explore new potential therapies for HCC patients.
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###### 

**Additional file 1: Figure S1. A.** The detailed images of the merged data in Fig. [1](#Fig1){ref-type="fig"}e.**B.** The detailed images of the merged data in Fig. [1](#Fig1){ref-type="fig"}h.**C.** The detailed images of the merged data in Fig. [2](#Fig2){ref-type="fig"}g.

HCC

:   Hepatocellular carcinoma

circRNA

:   Circular RNA

DENND4C

:   DENN domain containing 4C

TCF4

:   Transcription factor 4

ceRNA

:   Competing endogenous RNA

miRNA

:   MicroRNA

qRT-PCR

:   Quantitative Real-time PCR

FISH

:   Fluorescence in Situ Hybridization

RIP

:   RNA Immunoprecipitation

ChIP

:   Chromatin immunoprecipitation

ActD

:   Actinomycin D
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